Albireo Pharma

Albireo Pharma is a biopharmaceutical company focused on the development and commercialization of bile acid modulators to treat orphan pediatric liver diseases and gastrointestinal disorders. The initial target indication for the company's main product candidate, A4250, is progressive familial intrahepatic cholestasis (PFIC), a rare, life-threatening genetic disorder affecting young children for which there is no approved drug treatment. The company's product candidates in addition to A4250 include elobixibat, which is approved in Japan for the treatment of chronic constipation and A3384, which is a product candidate to treat bile acid malabsorption.
  • TickerALBO
  • ISINUS01345P1066
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountryUnited States

Analysts

ValuEngine Rating and Forecast Report for ALBO

ValuEngine Rating and Forecast Report for ALBO

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Liana Moussatos ...
  • Shveta Dighe

Elobixibat/NASH Ph2 Screening; Odevixibat/PFIC Ph3 Topline Results in Mid:20

ValuEngine Rating and Forecast Report for ALBO

ValuEngine Rating and Forecast Report for ALBO

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Liana Moussatos ...
  • Shveta Dighe

Elobixibat/NASH Ph2 Screening; Odevixibat/PFIC Ph3 Topline Results in Mid:20

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

ValuEngine Rating and Forecast Report for ALBO

ValuEngine Rating and Forecast Report for ALBO

ValuEngine Rating and Forecast Report for ALBO

ValuEngine Rating and Forecast Report for ALBO

ValuEngine Rating and Forecast Report for ALBO

ValuEngine Rating and Forecast Report for ALBO

ValuEngine Rating and Forecast Report for ALBO

ValuEngine Rating and Forecast Report for ALBO

ValuEngine Rating and Forecast Report for ALBO

ValuEngine Rating and Forecast Report for ALBO

ResearchPool Subscriptions

Get the most out of your insights

Get in touch